drugset / Trial / NCT00097812
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess bone mineral density in patients switching from an oral bisphosphonate to zoledronic acid, compared to those staying on the oral bisphosphonate.
Timeline
- Start
- 2004-05
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | — | — |